Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 2, 2026
Purchase
Shares
1,000
Price
$2.28
Total Value
$2.28K
Shares Held After
372,702
% of Holdings
0.3%
Mar 2, 2026
Purchase
Shares
2,000
Price
$2.00
Total Value
$4.00K
Shares Held After
627,813
% of Holdings
0.3%

Moderna, Inc. (MRNA)

Klinger Shannon Thyme — Chief Legal Officer
Mar 2, 2026
Sale
Shares
13,885
Price
$52.29
Total Value
$726.05K
Shares Held After
59,689
% of Holdings
18.9%

Beta Bionics, Inc. (BBNX)

Hopman Mark — Chief Commercial Officer
Mar 2, 2026
Sale
Shares
834
Price
$12.36
Total Value
$10.31K
Shares Held After
139,486
% of Holdings
0.6%

iRhythm Holdings, Inc. (IRTC)

Shrishrimal Sumi — EVP, Chief Risk Officer
Mar 2, 2026
Sale
Shares
978
Price
$128.44
Total Value
$125.62K
Shares Held After
41,870
% of Holdings
2.3%

iRhythm Holdings, Inc. (IRTC)

Shrishrimal Sumi — EVP, Chief Risk Officer
Mar 2, 2026
Sale
Shares
906
Price
$128.44
Total Value
$116.37K
Shares Held After
42,848
% of Holdings
2.1%

iRhythm Holdings, Inc. (IRTC)

Shrishrimal Sumi — EVP, Chief Risk Officer
Mar 2, 2026
Sale
Shares
946
Price
$128.44
Total Value
$121.50K
Shares Held After
43,754
% of Holdings
2.1%

Bausch Health Companies Inc. (BHC)

Carson Seana — EVP, General Counsel
Mar 2, 2026
Sale
Shares
6,856
Price
$5.78
Total Value
$39.63K
Shares Held After
776,076
% of Holdings
0.9%

Beta Bionics, Inc. (BBNX)

Russell Steven Jon — Chief Medical Officer
Mar 2, 2026
Sale
Shares
1,026
Price
$12.36
Total Value
$12.68K
Shares Held After
179,096
% of Holdings
0.6%

Atara Biotherapeutics, Inc. (ATRA)

Grant-Huerta Yanina — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
100
Price
$5.08
Total Value
$508.30
Shares Held After
31,750
% of Holdings
0.3%

Atara Biotherapeutics, Inc. (ATRA)

Grant-Huerta Yanina — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
377
Price
$5.08
Total Value
$1.92K
Shares Held After
31,850
% of Holdings
1.2%

Atara Biotherapeutics, Inc. (ATRA)

Grant-Huerta Yanina — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
1,603
Price
$5.08
Total Value
$8.14K
Shares Held After
32,227
% of Holdings
4.7%

Atara Biotherapeutics, Inc. (ATRA)

Grant-Huerta Yanina — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
24
Price
$5.08
Total Value
$121.85
Shares Held After
33,830
% of Holdings
0.1%

Gemini Therapeutics, Inc. (GMTX)

Savage William Jacob — Chief Medical Officer
Mar 2, 2026
Sale
Shares
2,986
Price
$66.41
Total Value
$198.30K
Shares Held After
85,211
% of Holdings
3.4%

Gemini Therapeutics, Inc. (GMTX)

Savage William Jacob — Chief Medical Officer
Mar 2, 2026
Sale
Shares
4,392
Price
$65.52
Total Value
$287.77K
Shares Held After
88,197
% of Holdings
4.7%
Mar 2, 2026
Sale
Shares
58,368
Price
$1.43
Total Value
$83.47K
Shares Held After
1,409,511
% of Holdings
4.0%
Mar 2, 2026
Sale
Shares
6,737
Price
$1.43
Total Value
$9.63K
Shares Held After
1,467,879
% of Holdings
0.5%
Mar 2, 2026
Sale
Shares
2,708
Price
$1.43
Total Value
$3.87K
Shares Held After
1,474,616
% of Holdings
0.2%

uniQure N.V. (QURE)

Kapusta Matthew C — Director
Mar 2, 2026
Sale
Shares
34,437
Price
$9.95
Total Value
$342.65K
Shares Held After
604,639
% of Holdings
5.4%

Oscar Health, Inc. (OSCR)

Baltrus Victoria — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
4,638
Price
$13.39
Total Value
$62.10K
Shares Held After
216,112
% of Holdings
2.1%
Mar 2, 2026
Sale
Shares
250
Price
$50.69
Total Value
$12.67K
Shares Held After
25,801
% of Holdings
1.0%

Oscar Health, Inc. (OSCR)

Liang Janet — President, Oscar Insurance
Mar 2, 2026
Sale
Shares
7,453
Price
$13.39
Total Value
$99.80K
Shares Held After
271,532
% of Holdings
2.7%
Mar 2, 2026
Sale
Shares
5,466
Price
$17.92
Total Value
$97.97K
Shares Held After
613,471
% of Holdings
0.9%
Mar 2, 2026
Purchase
Shares
1,000
Price
$22.53
Total Value
$22.53K
Shares Held After
7,397
% of Holdings
13.5%

Xeris Biopharma Holdings, Inc. (XERS)

Hecht Beth — Chief Legal Officer and Corporate Secretary
Mar 2, 2026
Sale
Shares
100
Price
$7.06
Total Value
$706.00
Shares Held After
1,226,507
% of Holdings
0.0%

Xeris Biopharma Holdings, Inc. (XERS)

Hecht Beth — Chief Legal Officer and Corporate Secretary
Mar 2, 2026
Sale
Shares
16,567
Price
$6.24
Total Value
$103.38K
Shares Held After
1,226,607
% of Holdings
1.3%

Oscar Health, Inc. (OSCR)

Blackley Richard Scott — Chief Financial Officer
Mar 2, 2026
Sale
Shares
19,221
Price
$13.39
Total Value
$257.37K
Shares Held After
1,466,660
% of Holdings
1.3%

uniQure N.V. (QURE)

Abi-Saab Walid — Chief Medical Officer
Mar 2, 2026
Sale
Shares
1,660
Price
$9.95
Total Value
$16.52K
Shares Held After
148,777
% of Holdings
1.1%

908 Devices Inc. (MASS)

McCallion Kevin J. — SVP, Products and Production
Mar 2, 2026
Sale
Shares
7
Price
$7.00
Total Value
$49.00
Shares Held After
44,918
% of Holdings
0.0%
Mar 2, 2026
Sale
Shares
1,860
Price
$23.18
Total Value
$43.11K
Shares Held After
1,203,667
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
14,292
Price
$22.67
Total Value
$323.99K
Shares Held After
1,205,527
% of Holdings
1.2%
Mar 2, 2026
Sale
Shares
7,229
Price
$39.66
Total Value
$286.72K
Shares Held After
316,545
% of Holdings
2.2%
Mar 2, 2026
Sale
Shares
24,335
Price
$13.39
Total Value
$325.85K
Shares Held After
514,986
% of Holdings
4.5%
Mar 2, 2026
Sale
Shares
42
Price
$203.57
Total Value
$8.55K
Shares Held After
42,720
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
50
Price
$202.54
Total Value
$10.13K
Shares Held After
42,762
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
83
Price
$201.65
Total Value
$16.74K
Shares Held After
42,812
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
41
Price
$200.40
Total Value
$8.22K
Shares Held After
42,895
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
204
Price
$199.69
Total Value
$40.74K
Shares Held After
42,936
% of Holdings
0.5%
Mar 2, 2026
Sale
Shares
47
Price
$197.14
Total Value
$9.27K
Shares Held After
43,140
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
4,314,939
Price
$7.01
Total Value
$30.25M
Shares Held After
29,209,776
% of Holdings
12.9%

uniQure N.V. (QURE)

KLEMT CHRISTIAN — Chief Financial Officer
Mar 2, 2026
Sale
Shares
12,532
Price
$9.95
Total Value
$124.69K
Shares Held After
198,981
% of Holdings
5.9%
Mar 2, 2026
Purchase
Shares
17,428
Price
$0.35
Total Value
$6.15K
Shares Held After
5,924,075
% of Holdings
0.3%
Mar 2, 2026
Sale
Shares
39,272
Price
$25.39
Total Value
$997.19K
Shares Held After
22,123
% of Holdings
64.0%
Mar 2, 2026
Sale
Shares
1,442
Price
$5.09
Total Value
$7.34K
Shares Held After
61,978
% of Holdings
2.3%
Mar 2, 2026
Sale
Shares
1,298
Price
$5.09
Total Value
$6.60K
Shares Held After
63,420
% of Holdings
2.0%
Mar 2, 2026
Sale
Shares
58
Price
$5.08
Total Value
$294.64
Shares Held After
64,718
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
198
Price
$5.08
Total Value
$1.01K
Shares Held After
64,776
% of Holdings
0.3%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Liu Joy — EVP and Chief Legal Officer
Mar 2, 2026
Sale
Shares
892
Price
$495.96
Total Value
$442.40K
Shares Held After
22,811
% of Holdings
3.8%
Mar 2, 2026
Sale
Shares
20,685,061
Price
$7.01
Total Value
$145.00M
Shares Held After
140,026,557
% of Holdings
12.9%

VERACYTE, INC. (VCYT)

Febbo Phillip G. — Chief Scientific & Med Officer
Mar 2, 2026
Sale
Shares
13,425
Price
$36.16
Total Value
$485.43K
Shares Held After
117,346
% of Holdings
10.3%
Version: v26.3.33